June 14, 2024

Tuberculosis and the Virome: Exploring the Role of Viruses in TB Pathogenesis and Treatment

https://images.app.goo.gl/51YDQgEM1er1F9oc9 Tuberculosis (TB) remains a global health concern, with millions of cases reported annually. While Mycobacterium tuberculosis is the primary causative agent, recent research has highlighted the role of viruses in TB pathogenesis and treatment outcomes. The virome, comprising a diverse array of viruses, interacts with the host immune system and microbiota, influencing disease progression […]

Tuberculosis and the Virome: Exploring the Role of Viruses in TB Pathogenesis and Treatment Read More »

Tuberculosis and the Lung Microbiome: Unraveling the Complex Interplay

https://images.app.goo.gl/YxvgBF7kdFvqsdbY6 Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, remains a significant global health concern, with millions of people affected each year. While the lungs are the primary target of this disease, recent research has shed light on the role of the lung microbiome in the development and progression of TB. Understanding the complex interplay

Tuberculosis and the Lung Microbiome: Unraveling the Complex Interplay Read More »

Digital Health Technologies in Tuberculosis Care

https://images.app.goo.gl/GnSboNqyVUmmJX9y5 Digital health technologies are becoming increasingly potent weapons in the fight against tuberculosis (TB), completely changing how the disease is treated and managed. These modern technologies are revolutionizing global healthcare delivery systems and improving patient outcomes, as well as diagnosis and treatment. Advancements in TB Diagnosis Since 1997, WHO has released an annual global

Digital Health Technologies in Tuberculosis Care Read More »

Tuberculosis Biomarkers: Advanced Early Detection and Treatment Monitoring

https://images.app.goo.gl/m27sZwKcQrcUJz979 As a major global health concern, tuberculosis (TB) requires improvements in treatment monitoring and early detection. Biomarkers are essential in these efforts because they provide information about diagnosis, therapy efficacy assessment, and outcome prediction. The urgent need to contain the TB pandemic and lower the disease’s death rate motivates researchers to search for new

Tuberculosis Biomarkers: Advanced Early Detection and Treatment Monitoring Read More »

New TB Medicines and Regimens: Responsible Use for MDR-TB Treatment

Source: https://tbcindia.gov.in/showfile.php?lid=3680 Tuberculosis (TB) remains a significant global health challenge, with multidrug-resistant TB (MDR-TB) posing a growing threat due to its resistance to first-line drugs. The development of new TB medicines and regimens offers hope for more effective treatment, especially for MDR-TB cases. However, responsible use of these new therapies is crucial to ensure optimal

New TB Medicines and Regimens: Responsible Use for MDR-TB Treatment Read More »

Scroll to Top